Rockefeller Capital Management
SANA icon

Rockefeller Capital Management’s Sana Biotechnology SANA Stock Holding History

Rockefeller Capital Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39.6K Buy
13,765
+4,177
+44% +$16.5K ﹤0.01% 3396
2025
Q4 		$39K Buy
9,588
+4,088
+74% +$18.3K ﹤0.01% 3189
2025
Q3 		$19.5K Buy
+5,500
New +$19.9K ﹤0.01% 3368

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Rockefeller Capital Management's SANA Position: Q1 2026 in Review

Rockefeller Capital Management increased its Sana Biotechnology (SANA) stake by 44% in Q1 2026, buying an estimated $16.5K and bringing the position to 13,765 shares worth $39.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3396.

Rockefeller Capital Management first reported a position in SANA in Q3 2025 and has held it in 3 quarters since. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Rockefeller Capital Management held 13,765 shares of Sana Biotechnology worth $39.6K as of Q1 2026.
  • Rockefeller Capital Management bought 4,177 Sana Biotechnology shares in Q1 2026, an estimated $16.5K.
  • Sana Biotechnology made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #3396 holding.
  • Rockefeller Capital Management first reported a position in Sana Biotechnology in Q3 2025 and has held it in 3 quarters since.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.